Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,060.00
Bid: 2,060.00
Ask: 2,062.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.097%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,060.00
WEIR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

20 Mar 2008 17:32

Weir Group PLC20 March 2008 NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to theshares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating theshares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and17 to 24. (4) An issuer making a notification in respect of a financial instrumentrelating to the shares of the issuer (other than a debenture) should completeboxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes should in block capital letters. 1. Name of the issuer 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or THE WEIR GROUP PLC (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (iii) BOTH 3. Name of person discharging 4. State whether notification managerial responsibilities/ relates to a person connected director with a person discharging managerial responsibilities/ director named in 3 and identify the connected person (1) ALAN MITCHELSON NO (2) KEITH COCHRANE (3) PHILIP CLIFTON (4) STEPHEN BIRD (5) SCOT SMITH (6) STEPHEN SIMONE (7) STEVE NOON 5. Indicate whether the notification 6. Description of shares (including is in respect of a holding of the class), debentures or derivatives person referred to in 3 or 4 above or financial instruments relating or in respect of a non-beneficial to shares interest 3 ABOVE ORDINARY SHARES OF 12.5P EACH 7. Name of registered shareholders(s) 8. State the nature of the and, if more than one, the number transaction of shares held by each of them (1) ALAN MITCHELSON 98441 PURCHASE OF SHARES UNDER THE GROUP LONG TERM INCENTIVE PLAN (2) KEITH COCHRANE 5185 (3) PHILIP CLIFTON 9527 (4) STEPHEN BIRD 1613 (5) SCOT SMITH 37583 (6) STEPHEN SIMONE 41592 (7) STEVE NOON nil 9. Number of shares, debentures or 10. Percentage of issued class financial instruments relating to acquired (treasury shares of that shares acquired class should not be taken into account when calculating percentage) (1) ALAN W F MITCHELSON 3589 N/A (2) KEITH COCHRANE 4638 (3) PHILIP J CLIFTON 1613 (4) STEPHEN BIRD 1764 (5) SCOT SMITH 1471 (6) STEPHEN A SIMONE 1072 (7) STEVE NOON 971 11. Number of shares, debentures or 12. Percentage of issued class financial instruments relating to disposed (treasury shares of that shares disposed class should not be taken into account when calculating percentage) NIL N/A 13. Price per share or value of 14. Date and place of transaction transaction 720.5p 20 MARCH 2008 15. Total holding following 16. Date issuer informed of notification and total percentage transaction holding following notification (any treasury shares should not be taken into account when calculating percentage) (1) ALAN W F MITCHELSON 102030 20 MARCH 2008 (2) KEITH COCHRANE 9823 (3) PHILIP J CLIFTON 11140 (4) STEPHEN BIRD 3377 (5) SCOT SMITH 39054 (6) STEPHEN A SIMONE 42664 (7) STEVE NOON 971 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17. Date of grant 18. Period during which or date on which it can be exercised 19. Total amount paid (if any) for grant 20. Description of shares or of the option debentures involved (class and number) 21. Exercise price (if fixed at time of 22. Total number of shares or grant) or indication that price is to debentures over which options be fixed at the time of exercise held following notification 23. Any additional information 24 Name of contact and telephone number for queries FRANCES MCCAW 0141 308 3737Name and signature of duly authorised officer of issuer responsible for makingnotification ..................FRANCES MCCAW................................................. Date of notification ...............20 March 2008 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Jun 20245:24 pmRNSDirector/PDMR Shareholding
28th May 202412:03 pmRNSDirector/PDMR Shareholding
23rd May 20244:58 pmRNSDirector/PDMR Shareholding
15th May 20247:39 amRNSDirectorate Change
13th May 20249:54 amRNSHolding(s) in Company
25th Apr 20244:06 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Update
15th Apr 20245:21 pmRNSDirector/PDMR Shareholding
15th Apr 20244:28 pmRNSDirector/PDMR Shareholding
15th Apr 20244:19 pmRNSDirector/PDMR Shareholding
15th Apr 20244:18 pmRNSDirector/PDMR Shareholding
10th Apr 20243:18 pmRNSDirector/PDMR Shareholding
10th Apr 20242:14 pmRNSDirector/PDMR Shareholding
10th Apr 20242:11 pmRNSDirector/PDMR Shareholding
5th Apr 202411:30 amRNSHolding(s) in Company
21st Mar 202410:44 amRNS2023 Annual Report and 2024 Annual General Meeting
13th Mar 202410:31 amRNSWeir opens new foundry in China
7th Mar 202411:04 amRNSHolding(s) in Company
29th Feb 20247:00 amRNSFull Year Results
27th Feb 20249:47 amRNSDirectorate Change
7th Feb 20248:48 amRNSHolding(s) in Company
6th Feb 20248:13 amRNSWeir achieves ‘A’ score from CDP
31st Jan 20248:07 amRNSDirectorate Change
19th Dec 202310:29 amRNSNew Board Committee and Board Changes
6th Dec 20237:00 amRNSWeir announces 2026 operating margin target of 20%
5th Dec 20233:09 pmRNSDirectorate Change
4th Dec 20231:30 pmRNSWeir study on energy in mining
23rd Nov 20237:00 amRNSWeir acquires SentianAI
14th Nov 20239:54 amRNSDirector/PDMR Shareholding
7th Nov 20239:04 amRNSDirector/PDMR Shareholding
3rd Nov 20233:51 pmRNSHolding(s) in Company
3rd Nov 20233:51 pmRNSHolding(s) in Company
1st Nov 20237:01 amRNSAppointment of Chief Financial Officer
1st Nov 20237:00 amRNSQ3 Trading Update
26th Oct 20231:55 pmRNSHolding(s) in Company
24th Oct 20238:39 amRNSDirectorate Change
2nd Oct 20237:00 amRNSCapital Markets Event – 6 December 2023
18th Aug 20235:13 pmRNSDirector/PDMR Shareholding
18th Aug 20235:00 pmRNSHolding(s) in Company
18th Aug 20232:44 pmRNSDirector/PDMR Shareholding
18th Aug 20232:30 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSHalf-year Report
31st Jul 20232:19 pmRNSTotal Voting Rights
28th Jul 20234:45 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSDirectorate change
27th Jul 20237:00 amRNSAppointment of John Heasley as Finance Director
13th Jul 202311:59 amRNSStabilisation Notice
30th Jun 20233:51 pmRNSTotal Voting Rights
14th Jun 20232:31 pmRNSHolding(s) in Company
12th Jun 20232:50 pmRNSDirector / PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.